Glasgow, Scotland, November 19, 2018 Rafina Innovations Inc. (formerly HCi Viocare) (OTCQB:VICA) , provides update on recent management changes. Rafina Innovations Inc. was created to be a dynamic technology start-up. Our strength lies in our exceptional sensor-technologies and the team behind them. Rafina Innovations Inc. has created the first... more
Glasgow, Scotland, Thursday July 12, 2018. HCi Viocare (OTCQB:VICA) , is pleased to announce that, further to our Current Report on Form 8-K filed June 15, 2018, HCi Viocare has completed a name change effective July 9, 2018 to Rafina Innovations Inc. Concurrently, the Company completed a reverse split on the basis of 20:1. The Company will trade... more
Glasgow, Scotland, Wednesday, January 31 st , 2018. HCi Viocare (OTCQB:VICA) , is pleased to announce that its management, acknowledging the tremendous advantages of Blockchain technology, has decided to develop its own proprietary Blockchain based system for handling the sensitive client records in its Scottish Clinics subsidiary. Furthermore,... more
GLASGOW, SCOTLAND--(Marketwired - Oct 9, 2017) - HCi Viocare ("the Company" ( OTCQB : VICA )) is delighted to welcome Dr. John Doupis, MD, PhD to its team. Dr. Doupis joins the Scientific Advisory Board assuming the role of Director of Clinical Matters and Diabetes. Dr. Doupis is a former Clinical Research Fellow of the Joslin Diabetes Center,... more
UPDATE Effective January 25 2018, Tharawat Holdings and HCi Viocare, have mutually decided that the formation of the JV that was agreed between them in July 2017, is no longer viewed as a strategic priority and have therfore terminated the Joint Venture Agreement between them. The management of HCi Viocare intents to re-evaluate this decision from... more
In April 2017 HCI Viocare's wholly owned UK based subsidiary, HCI Viocare Technologies Ltd. participated in a prestigious and collaborative research grant proposal along with the Imperial College of London and Ossur Inc. (the no. 2 manufacturer of prosthetic and orthotic devices in the world, with an annual sales of $521 million USD) as well as... more
Today we have started shipping our 4 th Generation Athletic Smart insoles to the sports shoes manufacturers with whom we are in discussions. The 4th Generation Smart insole is the closest to commercial-ready product due to its significantly higher level of durability and resolution , as well as its improved communication and connectivity... more
We are a granted participant of the 10th International Conference on Advanced Technologies & Treatments for Diabetes(ATTD) , this week in Paris . The Company has been recognized for its contribution to the development of innovative solutions in the diabetes prevention and treatment fields and has won a grant for its participation at the... more
We are pleased to announce that we have entered into discussions with Tharawat of the Kingdom of Saudi Arabia in order to examine market potential collaboration in Prosthetic, Orthotic and Diabetic Foot Clinics.more
HCi Viocare announces the appointment of Brian Maguire as Director of its subsidiary HCi Viocare Clinics. Brian Maguire, BSc., MISPO, MBAPO, is the Senior Prosthetist of the company's first clinic operating as a centre of excellence in Glasgow. He is HCPC registered and a member of BAPO. He holds a BSc in Prosthetics and Orthotics from the... more

Pages